We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Says More Studies Needed On Drug-Eluting Stent Risks
FDA Says More Studies Needed On Drug-Eluting Stent Risks
December 8, 2006
There is currently no evidence of increased rates of death or heart attack from drug-eluting stents versus bare-metal stents, but more trials with consistent protocols are needed to adequately assess the risk, an FDA panel concluded Dec. 7.